The economical role of RIOK3 in modulating the Jak1/STAT1 pathway and antiviral immunity against respiratory syncytial virus infection in macrophages: implications for therapeutic potential
- PMID: 40371100
- PMCID: PMC12075202
- DOI: 10.3389/fmicb.2025.1591473
The economical role of RIOK3 in modulating the Jak1/STAT1 pathway and antiviral immunity against respiratory syncytial virus infection in macrophages: implications for therapeutic potential
Abstract
Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections, particularly in vulnerable populations such as infants, the elderly, and immunocompromised individuals. RSV infection can result in mortality rates as high as 20%, attributable not only to viral replication but also to an excessive host immune response. Current therapeutic options are limited, partly due to gaps in understanding the host immune response, especially the role of macrophages and their signaling pathways. This study investigates the role of RIOK3, an unconventional kinase, in modulating the Jak1/STAT1 pathway during RSV infection in macrophages and its impact on viral replication and interferon production. Using both in vitro and in vivo models, including primary bone marrow-derived macrophages (BMM) from control and RIOK3 knockout (KO) mice, we demonstrate that RIOK3 is a critical regulator of the Jak1/STAT1 pathway in macrophages during RSV infection. The absence of RIOK3 enhances viral replication and disrupts the balance of type I interferons. Targeting RIOK3 may represent a promising strategy to enhance antiviral immunity and mitigate RSV-induced inflammation, thus warranting further investigation for therapeutic potential.
Keywords: Jak1/STAT pathway; RIOK3; RSV; macrophage; type I interferon.
Copyright © 2025 Sun, Liang, Qian and Hu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.J Virol. 2021 Oct 27;95(22):e0091221. doi: 10.1128/JVI.00912-21. Epub 2021 Aug 25. J Virol. 2021. PMID: 34431698 Free PMC article.
-
Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway.Virol J. 2020 Nov 25;17(1):187. doi: 10.1186/s12985-020-01451-6. Virol J. 2020. PMID: 33239033 Free PMC article.
-
Differential Role of Anti-Viral Sensing Pathway for the Production of Type I Interferon β in Dendritic Cells and Macrophages Against Respiratory Syncytial Virus A2 Strain Infection.Viruses. 2019 Jan 15;11(1):62. doi: 10.3390/v11010062. Viruses. 2019. PMID: 30650519 Free PMC article.
-
An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.J Virol. 2022 Oct 12;96(19):e0129722. doi: 10.1128/jvi.01297-22. Epub 2022 Sep 14. J Virol. 2022. PMID: 36102648 Free PMC article. Review.
-
Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology.Biochemistry (Mosc). 2021 Mar;86(3):290-306. doi: 10.1134/S0006297921030068. Biochemistry (Mosc). 2021. PMID: 33838630 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous